Isolated morular squamous metaplasia in endometrial biopsies and curettings: is there a role for repeated sampling?

Isolated squamous morular metaplasia without associated glandular neoplasia is a rare finding, reported only in 0.17% of endometrial samples. The risk of subsequent endometrioid neoplasia appears to be low (5.4%), although the possibility of undersampled atypical hyperplasia/endometrioid carcinoma cannot be completely ruled out without additional sampling. Persistent squamous morular metaplasia is relatively uncommon (4.5%) and may not lead to the subsequent diagnosis of endometrial cancer, questioning the utility of numerous repeat samplings in patients without progression after one repeat sample.

Authors

Institutions

Publication Details

Journal
Histopathology
Published
2025-11-26
DOI
https://doi.org/10.1111/his.70054
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Isolated morular squamous metaplasia in endometrial biopsies and curettings: is there a role for repeated sampling?

Gulisa Turashvili, Lawrence Hsu Lin, Valentina Zanfagnin, Esther Oliva et al.
Histopathology
Endometrial and Cervical Cancer Treatments
article

Isolated morular squamous metaplasia in endometrial biopsies and curettings: is there a role for repeated sampling?

Gulisa Turashvili, Lawrence Hsu Lin, Valentina Zanfagnin, Esther Oliva, Kyle M. Devins
article en

Abstract

Isolated squamous morular metaplasia without associated glandular neoplasia is a rare finding, reported only in 0.17% of endometrial samples. The risk of subsequent endometrioid neoplasia appears to be low (5.4%), although the possibility of undersampled atypical hyperplasia/endometrioid carcinoma cannot be completely ruled out without additional sampling. Persistent squamous morular metaplasia is relatively uncommon (4.5%) and may not lead to the subsequent diagnosis of endometrial cancer, questioning the utility of numerous repeat samplings in patients without progression after one repeat sample.

HistopathologyVol. 88(4)
Harvard University (US), Massachusetts General Hospital (US)
Openalex Percentile: Top 53%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.